Top 5 Most Read RNS's on Vox Markets for Wednesday 26th April 2023
Episode 1364, Apr 26, 2023, 06:48 AM
Top 5 Most Read RNS's on Vox Markets for Wednesday 26th April 2023
1. Supply @ME Capital #SYME - Commitment for first Inventory Monetisation from traditional funding.
SYME has secured a binding commitment provided by an institutional investor to invest in the first IM using traditional funding sources, pursuant to the Company's action plan to work with a consortium of European investors to fund IM transactions with monetisable value of up to €5m, as announced on 20 January 2023.
The Commitment provided by the Investor will be used by the StockCo to monetise up to €1.2m of warehoused goods of an Italian client company, which is one of the market leaders in the tyre re-treading sector with operations around the world.
2. Polarean Imaging #POLX - First order for XENOVIEW gas blend received
Polarean Imaging announces that it has received its first order for a gas blend cylinder for the production of XENOVIEW from Cincinnati Children's Hospital Medical Center. XENOVIEW is the only hyperpolarised contrast agent approved by the U.S. FDA for use with magnetic resonance imaging (MRI) for the evaluation of lung ventilation in adults and paediatric patients aged 12 years and older.
3. hVIVO #HVO - FDA Breakthrough and Fast Track for US biotech
hVIVO notes the announcements dated 13 April 2023 and 18 April 2023 from SAB Biotherapeutics (NASDAQ: SABS), reporting that the US FDA has granted Breakthrough Therapy and Fast Track designations for its investigational therapeutic for the treatment of seasonal influenza, SAB-176. hVIVO conducted a Phase 2a human challenge trial to assess the efficacy of SAB-176 using its Influenza Human Challenge Study Model.
4. Atlantic Lithium #ALL - International Lithium Association Membership
Atlantic Lithium announce that it has become an Associate Member of the International Lithium Association (ILiA), the global trade association for the lithium industry.
ILiA is a not-for-profit association based in London, founded in 2021 by some of the leading global lithium producers, at a time when the market for lithium was rapidly changing. Today more than 85% of the lithium industry is part of ILiA.
5. Alien Metals #UFO - Elizabeth Hill and Hancock Project Updates
Alien Metals is pleased to deliver a maiden JORC compliant Mineral Reserve for the Company's flagship Hancock Iron Ore Project, situated in the prolific iron ore producing region of the Pilbara, Western Australia.
Ore Reserve: 1.9Mt @ 60.2% Fe
Updated JORC Mineral Resource Estimate (using a 58% cut off grade):
o Indicated Resource 1.7Mt @ 61.0% Fe
o Inferred Resource 7.4Mt @ 60.1% Fe
o Global Resource 9.1Mt @ 60.3% Fe
Inaugural declaration of Indicated Mineral Resources of 1.7 million tonnes ("Mt") @ 61.0% Fe
1. Supply @ME Capital #SYME - Commitment for first Inventory Monetisation from traditional funding.
SYME has secured a binding commitment provided by an institutional investor to invest in the first IM using traditional funding sources, pursuant to the Company's action plan to work with a consortium of European investors to fund IM transactions with monetisable value of up to €5m, as announced on 20 January 2023.
The Commitment provided by the Investor will be used by the StockCo to monetise up to €1.2m of warehoused goods of an Italian client company, which is one of the market leaders in the tyre re-treading sector with operations around the world.
2. Polarean Imaging #POLX - First order for XENOVIEW gas blend received
Polarean Imaging announces that it has received its first order for a gas blend cylinder for the production of XENOVIEW from Cincinnati Children's Hospital Medical Center. XENOVIEW is the only hyperpolarised contrast agent approved by the U.S. FDA for use with magnetic resonance imaging (MRI) for the evaluation of lung ventilation in adults and paediatric patients aged 12 years and older.
3. hVIVO #HVO - FDA Breakthrough and Fast Track for US biotech
hVIVO notes the announcements dated 13 April 2023 and 18 April 2023 from SAB Biotherapeutics (NASDAQ: SABS), reporting that the US FDA has granted Breakthrough Therapy and Fast Track designations for its investigational therapeutic for the treatment of seasonal influenza, SAB-176. hVIVO conducted a Phase 2a human challenge trial to assess the efficacy of SAB-176 using its Influenza Human Challenge Study Model.
4. Atlantic Lithium #ALL - International Lithium Association Membership
Atlantic Lithium announce that it has become an Associate Member of the International Lithium Association (ILiA), the global trade association for the lithium industry.
ILiA is a not-for-profit association based in London, founded in 2021 by some of the leading global lithium producers, at a time when the market for lithium was rapidly changing. Today more than 85% of the lithium industry is part of ILiA.
5. Alien Metals #UFO - Elizabeth Hill and Hancock Project Updates
Alien Metals is pleased to deliver a maiden JORC compliant Mineral Reserve for the Company's flagship Hancock Iron Ore Project, situated in the prolific iron ore producing region of the Pilbara, Western Australia.
Ore Reserve: 1.9Mt @ 60.2% Fe
Updated JORC Mineral Resource Estimate (using a 58% cut off grade):
o Indicated Resource 1.7Mt @ 61.0% Fe
o Inferred Resource 7.4Mt @ 60.1% Fe
o Global Resource 9.1Mt @ 60.3% Fe
Inaugural declaration of Indicated Mineral Resources of 1.7 million tonnes ("Mt") @ 61.0% Fe